%20(8).png){kind=small}
BACKED BY SCIENCE,
TRUSTED WORLDWIDE
Developed in Italy through years of collaboration between biomedical engineers, physicians, and researchers, Echolight is CE-certified in Europe, FDA-cleared in the United States, and validated in over 100 clinical studies.
Its REMS technology is revolutionizing bone health by making assessment safer, more accurate, and more accessible than ever before.
ECHOLIGHT CASE STUDIES
The following peer-reviewed studies and clinical trials highlight Echolight’s accuracy, reliability, and global impact. From early detection of osteoporosis to monitoring long-term bone health, these papers showcase how REMS technology is changing patient care.
Osteoporosis in 10 years time: a glimpse into the future of osteoporosis
Radiofrequency echographic multi spectrometry for the prediction of
incident fragility fractures: A 5-year follow-up study
Cost-minimization analysis to support the HTA of Radiofrequency Echographic Multi Spectrometry (REMS) in the diagnosis of osteoporosis
Could radiofrequency echographic
multispectrometry (REMS) overcome the overestimation in BMD by dual‑energy X‑ray absorptiometry (DXA) at the lumbar spine?
Ability of radiofrequency echographic multispectrometry to identify
osteoporosis status in elderly women with type 2 diabetes
Radiofrequency echographic multispectrometry (REMS): an innovative technique for the assessment of bone status in young women with anorexia nervosa
Radiofrequency Echographic Multi Spectrometry (REMS) for the diagnosis of osteoporosis in a European multicenter clinical context
First assessment of bone mineral density in healthy pregnant women by means of Radiofrequency Echographic Multi Spectrometry (REMS) technology
Radiofrequency echographic multi-spectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck
Radiofrequency echographic multi‑spectrometry for the in‑vivo
assessment of bone strength: state of the art—outcomes of an expert consensus meeting...
Radiofrequency echographic multi‑
spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting
Radiofrequency echographic multi spectrometry (REMS) in the diagnosis and management of osteoporosis: state of the art
